The yeast spindle pole body (SPB) component Spc110p (Nuf1p) undergoes specific serine/threonine phosphorylation as the mitotic spindle apparatus forms, and this phosphorylation persists until cells enter anaphase (Friedman, D., Sundberg, H., Huang, E., and Davis, T. (1996) J. Cell Biol. 132, 903-914).
Introduction
Centrosomes are microtubule organizing centers that serve as the poles of mitotic spindles during eukaryotic cell division. Each mitotic cell cycle, the centrosome must duplicate once in preparation to form the spindle apparatus. The mitotic spindle is instrumental for proper segregation of the duplicated chromosomes into two euploid daughter cells, each receiving one of the centrosomes.
Proper centrosome function is vital to cell proliferation, and errors in centrosome duplication, spindle formation or spindle function can lead to chromosome instability, chromosome nondisjunction and aneuploidy.
Several lines of evidence from a wide variety of organisms suggest that protein phosphorylation plays a major role in centrosome control during the cell cycle. The MPM-2 monoclonal antibody recognizes mitosis-specific centrosomal phosphoepitopes in mammalian cells, A. nidulans and S.
pombe (1) (2) (3) , and MPM-2 antibodies inhibit microtubule nucleation in vitro (4) . Several protein kinases have been implicated in centrosome control by their mutant phenotype, including yeast Mps1p (5, 6) and Drosophila aurora (7) . In vertebrates, CDK2/cyclinE is important for initiation of centrosome duplication (8) (9) (10) , and Nek2p is important for centrosome separation (11) . Studies involving phosphatases and phosphatase inhibitors indicate that dephosphorylation is equally important for proper centrosome regulation (12) (13) (14) (15) .
carboxyl-terminal globular domain of Spc110p is located at the central plaque of the SPB (17, 18) , and has been shown to interact with the SPB components calmodulin, Spc29p and Spc42p (17, (19) (20) (21) (22) .
The amino-terminal globular domain of Spc110p is located at the inner plaque, where Tub4p, Spc97p and Spc98p are found (18, 23) . The amino-terminal globular domain of Spc110p interacts both genetically and biochemically with these components of the Tub4p-complex (19, (23) (24) (25) . Spc110p is also a phosphoprotein, and phosphorylation of Spc110p at serine/threonine residues arises as cells form the mitotic spindle and disappears as cells enter anaphase (26, 27) .
The dual-specificity kinase Mps1p is essential for SPB duplication and for mitotic checkpoint control in Saccharomyces cerevisiae (6) . Cells harboring the temperature-sensitive mps1-1 allele fail to duplicate the SPB at the restrictive temperature yet proceed through a doomed mitosis with a monopolar spindle (5) . Mps1p is also involved in the mitotic checkpoint (28) . High levels of Mps1p cause cells to arrest in metaphase, and these arrested cells contain hyperphosphorylated Mad1p, which is also associated with activation of the mitotic checkpoint (29) . In vitro, GST-Mps1p phosphorylates Mad1p (29) as well as Spc98p, a component of the Tub4p-complex (30) .
Despite the recent boon in centrosome component identification (for example, see reference 31) and the implication that several kinases are involved in centrosome function, direct evidence of specific phosphorylation of a centrosome component by a specific kinase in vivo has been lacking. In this study, we demonstrate that the dual-specificity kinase Mps1p phosphorylates Spc110p in vitro and that these sites are important for the mitosis-specific phosphorylation of Spc110p in vivo. These phosphorylations occur within the amino-terminal globular domain of Spc110p which resides at the inner plaque of the SPB and interacts with components of the microtubule-organizing Tub4p complex.
Mutating these phosphorylated residues to alanine (to prevent phosphorylation), but not to aspartate (to 6 mimic phosphorylation), perturbs the function of Spc110p such that it can no longer support growth in the presence of mutant forms of Spc97p, a component of the Tub4p complex. This perturbation also requires another alanine substitution at S36 in the amino-terminal globular domain, which is within an S/TPXR/K consensus sequence for phosphorylation by cdc2p/Cdc28p cyclin-dependent kinase (32, 33) . Thus, proper interaction of the Tub4p-complex with the yeast centrosome may require Spc110p phosphorylation at all four of these sites.
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Experimental Procedures
Media, Strains, and Genetic Manipulations--SD complete, SD-uracil (34) , SD-uracil low adenine (17) , YPD and YPD low adenine, and LB (35) were described previously. SD-uracil+uracil is SD-uracil supplemented with 25 µg/ml uracil. LB amp is LB medium supplemented with 100 µg/ml ampicillin. LB amp kan is LB amp medium supplemented with 6 µg/ml kanamycin. Plasmid transformations were carried out by the LiOAc method essentially as described (36) .
Strains are listed in Table 1 . The spc110-4A allele was integrated into CRY1 by a two step gene replacement (37) using plasmid pJK24 cut with SnaBI, creating strain JKY1. The presence of the spc110-4A allele was confirmed by sequencing. Synthetic lethal interactions between spc110-4A and spc97-114 were tested by crossing strain JKY1 (spc110-4A) with strain TNY64-5C (spc97-114).
Neither single mutant confers a temperature-sensitive phenotype. The diploid was sporulated and the tetrads dissected giving 25 tetratypes (1:3 temperature-sensitive:non-temperature-sensitive), 4 non parental ditypes (2:2), and 3 parental ditypes (0:4). Overall, 25.8% of the spore-clones from these dissections could not form colonies at 37 o C.
Immunoblot Analysis, α-Factor Arrest and Cytological Techniques--Immunoblot analysis, α-factor arrests, cell morphology characterization, and flow cytometry were performed as described (26) .
Plasmids--Plasmids are listed in Table 2 . pCL5 expresses ArgU, an arginine-tRNA AGA/AGG (AGA and AGG are rare codons in E. coli but common in yeast). pCL5 contains the pA15 origin of replication to allow for co-expression with plasmids containing the ColEI origin of replication. Plasmid pDV29 encoding GST-Spc110p (SPC110 Genbank accession number Z11582) was constructed by cloning the NcoI-EcoRI fragment from pDV17 (25) into the SmaI and EcoRI sites of pGEX-2T 8 (Pharmacia, Piscataway, NJ). Plasmids pJK2, pJK4 and pJK7 were made by site-directed mutagenesis of plasmid pDV29 using the Pharmacia Biotech USE Kit (Pharmacia, Piscataway, NJ) according to the manufacturer's directions. All other pJK plasmids (except pJK24) were made by sitedirected mutagenesis of the parent plasmid using the Stratagene QuikChange kit (Stratagene, La Jolla, CA) according to the manufacturer's directions. Plasmid pJK21 carrying URA3, CEN and an spc110 allele was converted to integrating plasmid pJK24 by replacing the AlwNI fragment containing part of bla, CEN and part of URA3 with the AlwNI fragment from pRS306 containing part of bla and part of URA3 but no CEN. Plasmids pDF47 and pDF48, which express 12xHIS-Spc110p fusion proteins, were constructed in several steps. First, a 6xHis tag was inserted at the initiator MET of SPC110 in plasmid pHS31 by site-directed mutagenesis as described in (26), creating pDF18. Plasmid pDF29 encodes the functional SPC110-201 allele containing an in-frame deletion of the coding sequences for residues 267-543 within the central coiled-coil (26) . Plasmid pDF30 (6xHIS-SPC110-201) was constructed by swapping a 1.6 kb HindIII fragment from pDF29 into pDF18. pDF47 expresses 12xHIS-Spc110-201p (756∆) (missing residues 267-543 within the central coiled-coil and truncated at residue 756 of Spc110p) and was constructed by cloning the SphI-SspI fragment from pDF30 into the SphI and SmaI sites of the 6xHis bacterial expression vector pQE32. pDF48 expresses 12xHIS-Spc110 (truncated at residue 225 of Spc110p) and was constructed by cloning the SphI-NsiI fragment from pDF30 into the SphI and PstI sites of pQE32.
Production of Spc110p
Fusion Proteins--Cultures of E. coli strain GM1 were transformed to ampicillin resistance with plasmids pDF47 or pDF48 expressing recombinant 12xHIS-Spc110-201p (756∆) or 12xHIS-Spc110p , respectively. Cultures of isolated transformants were diluted 1:100 into 10 ml LB amp, grown to a density of 20 Klett units and then induced with 1-2 mM IPTG for by guest on July 7, 2017 http://www.jbc.org/ Downloaded from 5 hours at 30 o C. Cells were harvested, washed once in lysis buffer (1x PBS, 10mM βME, 1mM PMSF) and lysed using a French Pressure cell (3/8 inch piston diameter; Aminco) at 11,000 p.s.i. to near 100% lysis. Wild-type and mutant forms of recombinant GST-Spc110p were co-expressed with plasmid pCL5 in strain GM1. Overnight cultures were diluted 1:200 into 200 ml LB amp kan and grown at 37 o C to a density of 60-70 Klett units. IPTG was added to a final concentration of 40 µg/ml and cultures were incubated for an additional 1.5 hours. Cells were then pelleted at 8,500x g for 10 minutes and pellets were stored at -80 o C. Thawed pellets were suspended in 3 ml of cold lysis buffer (1x PBS, 10mM βME, 1mM PMSF) and lysed in a French Pressure cell as described above. Triton X-100 was added to a final concentration of 1% and the lysate was incubated on ice for 15 minutes.
Cleared lysates were mixed for 1 hour with 100 µl glutathione Sepharose 4B resin (Pharmacia, Piscataway, NJ). The supernatant was then discarded and the beads washed three times with 1 ml lysis buffer. GST-Spc110p was eluted in 200 µl elution buffer (10mM Glutathione, 50 mM Tris pH 8.0) by mixing for 10 minutes. The buffer was exchanged to storage buffer (50 mM Tris-pH 7.5, 10 mM MgCl 2 , 50 mM NaCl, 0.5 mM DTT, 5% v/v glycerol) by gel filtration on G-25 Sephadex.
Samples were frozen in liquid N 2 and stored at -80 o C.
Mps1p
In Vitro Kinase Assay--All reactions were carried out as described in (6) except as follows. Kinase assays used to generate phosphorylated GST-Spc110p for analysis of phosphorylation sites by mass spectrometry used 200 µl of GST-Mps1p bound to GSH-Sepharose in a 50% slurry, which was washed once in kinase assay buffer without ATP (KAB-ATP: 50 mM Tris pH 7.5, 10 mM MgCl 2 , 2 mM DTT) and resuspended in 50 µl KAB-ATP and 10 µl of GST-Spc110p at a concentration of 1 mg/ml. 40 µl of 5x KAB (final concentration 50 mM Tris pH 7.5, 10 mM 
Results
Mps1p Activity is Necessary for Mitosis-Specific Phosphorylation of Spc110p In Vivo--
Previously we have shown that the 110-kD SPB component Spc110p undergoes serine/threonine phosphorylation in cells containing pre-anaphase mitotic spindles, which results in a slower-migrating isoform (p120) during SDS-PAGE (26) . We analyzed the Spc110p mobility shift in cells carrying the mps1-1 mutation at the restrictive temperature to determine whether the essential dual-specificity kinase Mps1p played a role in the mitosis-specific Spc110p phosphorylation. Mps1-1p is a severely crippled conditional mutant kinase, both in vivo and in vitro (38) . Cells were first synchronized in G1 by the addition of the mating pheromone α-factor and then released into pre-warmed MPS1 has at least two previously identified execution points during the cell cycle, one that is essential for SPB duplication (5) , and another that is involved in the mitotic spindle checkpoint (28) .
Because the mitosis-specific phosphorylation of Spc110p does not occur until after SPB duplication is complete (26) , it is possible that the dependence for Spc110p phosphorylation on Mps1p function merely reflects a prerequisite for SPB duplication. To test this hypothesis, we performed similar analyses for Spc110p phosphorylation at the restrictive temperature in two additional mutant backgrounds that block SPB duplication, mps2-1 and cdc31-2. Both mutations cause cells to arrest with large buds and a G2 DNA content at the restrictive temperature. Cells carrying the mps2-1 mutation arrest at the restrictive temperature with a malformed duplicated SPB that fails to insert into the by guest on July 7, 2017 http://www.jbc.org/ Downloaded from nuclear envelope and lacks both the inner plaque and nuclear microtubules (5) . Cells carrying the cdc31-2 mutation fail completely in SPB duplication (39) . The slower migrating mitosis-specific isoform of Spc110p is present at the restrictive temperature in each mutant background despite failures in SPB duplication ( Figure 2 ). Furthermore, ordering of execution points during the cell cycle place CDC31 function first, followed by MPS1 function and then by MPS2 function (5). Thus failure of the mitosisspecific phosphorylation of Spc110p in mps1-1 cells is not due simply to a failure in SPB duplication.
We also tested if MPS1 expression could promote the production of the mitosis-specific Spc110p isoform in cells blocked in G1 by the addition of α-factor, a state where the mitosis-specific isoform is normally not present (26) . Cells expressing MPS1 from a galactose-inducible promoter while held at this G1 arrest clearly produce the mitosis-specific Spc110p isoform ( Figure 3 demonstrating that the Spc110p mobility shift promoted by the expression of MPS1 during G1 arrest does not result from phosphorylation at inappropriate sites. Since other mitosis-specific functions would be turned off during this G1 arrest, it is likely that the production of the slower-migrating Spc110p isoform, which normally results from mitosis-specific phosphorylation, here results directly from the inappropriate expression of Mps1p.
Mps1p Phosphorylates Spc110p In Vitro at Sites Within the Amino-Terminal Globular
Domain of Spc110p--We expressed different forms of recombinant Spc110p in E. coli, and the lysates were added to an in vitro GST-Mps1p kinase assay (6) . GST-Mps1p (purified from yeast)
coiled-coil region and the last 188 residues of the carboxyl-terminal globular domain ( Figure 4A , lane 2). 12xHIS-Spc110p , which consists of the first 225 amino acids and encompasses the aminoterminal globular domain of Spc110p, was also phosphorylated in vitro by GST-Mps1p ( Figure and 12xHIS-Spc110p were nearly identical, exhibiting three major 
S60, T64 and T68 in Spc110p are Phosphorylated by GST-Mps1p In Vitro--We used an
E. coli expressed GST-Spc110p fusion protein containing the first 183 residues of Spc110p as a substrate for GST-Mps1p to determine the in vitro sites of phosphorylation by GST-Mps1p within the amino terminal globular domain of Spc110p. Stoichiometry of phosphorylation in three experiments by guest on July 7, 2017 http://www.jbc.org/ Downloaded from ranged from 0.9 to 1.7 mole phosphate per mole GST-Spc110p , and this phosphorylation produced a mobility-shift of GST-Spc110p on SDS-PAGE ( Figure 5A ).
The phosphorylated GST-Spc110p was digested with trypsin or endoLysC and the peptides were analyzed by MALDI-TOF and ESI-LC/MS mass spectrometry. This analysis accounted for every serine, threonine and tyrosine residue within the first 183 residues of Spc110p, and identified four tryptic peptides and two endoLysC peptides that appeared to be phosphopeptides based upon mass increases of 80 Da (or multiples thereof) over the expected masses for these peptides. All candidate phosphopeptides encompassed the residues S 60 IDDTIDSTR 69 within the amino terminal globular domain of Spc110p. Two representative fragmentation spectra of these phosphopeptides are described below.
The tryptic fragment S 60 IDDTIDSTR 69 (Tp60-69) was found to contain a single phosphate.
Sequencing this peptide by collision-induced dissociation during ESI-LC/MS/MS confirmed this assignment and mapped the site of phosphorylation to residue T64 ( Figure 5B ). This peptide, containing phosphorylation at T64, was also identified from the lower of the three spots in the 2-dimensional phosphopeptide maps shown in Figure 3 (data not shown). In the endoLysC digest, monoand di-phosphorylated forms of the peptide R 56 QRRSIDDTIDSTRLFSEASQFDDSFPEIK 85 (K56-85) were observed. The fragmentation spectrum of the di-phosphorylated form of K56-85 by ESI-LC/MS/MS showed heterogeneity in phosphorylation at any two of the three residues S60, T64 and T68 ( Figure 5C,D) . Several fragment ions indicated both phosphorylated (addition of HPO 4 or neutral loss of H 3 PO 4 ) as well as unmodified S60 (denoted by * in Figure 5C and detailed in Figure 5D ).
Fragment ions containing all three residues S60, T64 and T68 were found in the mono-or diphosphorylated forms, but never at their expected, unmodified masses. Thus, a mixture of di-phosphorylated forms of this peptide (phosphorylated at any two of these three sites) co-eluted from the reverse phase resin and were fragmented simultaneously during the LC/MS/MS experiment. A triphosphorylated form of K56-85 was not found.
Sites of in vitro Spc110p phosphorylation by Mps1p were confirmed by repeating the kinase assays using GST-Spc110p fusions containing combinations of alanine substitutions at residues S60, T64 and T68 ( Figure 6 ). The level of phosphate incorporation for each single mutant was decreased relative to the wild-type level (80%, 40% and 50% that of the wild-type level for the single mutants S60A (not shown in Figure 6 ), T64A and T68A, respectively). The level of phosphate incorporation into the T64A, T68A double mutant was 20% that of the wild-type level, and the level for the triple mutant S60A, T64A, T68A was reduced to near background levels ( Figure 6 ).
The kinase assays using mutant GST-Spc110p fusions as substrates confirmed phosphorylation at T68. The MS/MS spectrum for K56-85 does not clearly distinguish between phosphorylation at S67 and T68 ( Figure 5C and data not shown). However, phosphorylation of GSTSpc110p containing the T68A mutation was reduced relative to the wild-type protein as stated above, while the same fusion protein containing the S67A mutation was indistinguishable from the wildtype protein in this assay (data not shown). In addition, the mobility shift of GST-Spc110p observed during the in vitro kinase assay was dependent upon the presence of T68 (Figure 6 ). (19) , is synthetically lethal with alleles of SPC97 and SPC98 (25) . We find that full-length Spc110p containing any of the S60A, T64A or T68A mutations, by guest on July 7, 2017 http://www.jbc.org/ Downloaded from in conjunction with an alanine substitution at S36, fails to complement the synthetic lethality between spc110-221 and spc97-62 or spc97-114 (Table 3 , lines 5-9). We have also found that S36 is phosphorylated in Spc110p when expressed in insect cells 2 . The S36A substitution alone was still able to complement spc110-221 spc97 synthetic lethality, as was the triple Mps1p site substitution (Table 3, lines 2-4). Full-length Spc110p containing aspartate substitution at S36, S60, T64 and T68 was also able to complement the synthetic lethality (Table 3 , lines 10-11), suggesting that the effects due to the alanine substitutions were not due to an overall perturbation of protein structure. In contrast, the synthetic lethality between spc110-221 and an allele of Spc98p (spc98-63) was still suppressed by the quadruple alanine substitution Spc110p (Table 3, 
Discussion
We have shown previously that the mitosis-specific serine/threonine phosphorylation of Spc110p occurs after SPB duplication is completed as the mitotic spindle first forms, and persists up to the metaphase/anaphase transition (26) . We show here that the dual-specificity kinase Mps1p phosphorylates Spc110p and that this phosphorylation is necessary for the production of the mitosisspecific Spc110p isoform in vivo. Mitosis-specific Spc110p phosphorylation can occur in the absence of proper SPB duplication but cannot occur in the absence of Mps1p activity, and Mps1p production during G1 arrest can drive formation of the mitosis-specific Spc110p isoform. Spc110p is phosphorylated at residues S60, T64 and T68 by GST-Mps1p in vitro, and alanine substitution at these sites abolishes the mitosis-specific phosphorylation in vivo. These sites of phosphorylation are in the amino-terminal globular domain of Spc110p, which resides at the inner plaque of the SPB and interacts with members of the microtubule-nucleating Tub4p complex (19, (23) (24) (25) .
In vivo, alanine substitution at the Mps1p phosphorylation sites in Spc110p is synthetically lethal with alleles of SPC97, which encodes a component of the Tub4p complex. This synthetic lethality also requires an additional alanine substitution at residue S36. S36 falls within an S/TPXR/K consensus sequence for phosphorylation by cdc2p/Cdc28p cyclin-dependent kinase (32, 33) , and S36 is by guest on July 7, 2017 http://www.jbc.org/ Downloaded from phosphorylated when Spc110p is purified from insect cells 2 . We have shown previously that S36 does not contribute to the mitosis-specific Spc110p isoform (26) , and those findings are reiterated in this study ( Figure 7, lane 6) . However, the S36A mutation is required for synthetic lethality with alleles of SPC97, and in the presence of the S36A mutation, alanine substitution at any one of the three Mps1p sites is all that is required to produce the synthetic lethal phenotype.
Simultaneous aspartate substitution at S36 and the Mps1p sites does not interfere with Spc110p function, including the ability to complement synthetic lethality between alleles of spc110 and spc97. Whereas alanine substitution at serine and threonine residues is thought to prohibit side-chain phosphorylation without perturbing overall protein structure, aspartate substitutions at these residues are thought to mimic phosphorylation owing to the bulky, negatively-charged aspartate residue side chain.
Thus the phenotype associated with the alanine substitution Spc110p is not due simply to an overall perturbation of protein structure, but more likely to a specific defect due to the loss of phosphorylation at these residues.
The mitosis-specific phosphorylation of Spc110p occurs at a time when spindles first form (26) , and alleles containing alanine substitutions at S36 and the Mps1p sites perturb the interaction between Spc110p and Spc97p. It is tantalizing to suggest that Spc110p phosphorylation is important for proper interaction with the Tub4p complex. However, it is important to note that the spc97-114 allele exhibits a number of genetic interactions both with mutations in SPC110 and with genes encoding components of the Tub4p complex (25) . Thus the synthetic lethality between spc110-4A and spc97-114 reflects a defect in Spc110p function, but does not specify which function of Spc110p is compromised. In contrast, the spc110-4A allele was still able to complement synthetic lethality between spc110-221 and spc98-63 (Table 3 , line 9). The fact that the spc98-63 allele tested here was unperturbed by the spc110-4A allele is not surprising, since spc98-63 has defects that are specific to the spc110-221 and spc110-222 alleles and exhibits no genetic interactions with other mutations in SPC110 or with mutations in the Tub4p complex components ((25) and unpublished results).
Mps1p has a demonstrated role in both SPB duplication and the mitotic spindle checkpoint (6, 28, 29) . A role for Mps1p during mitotic spindle formation has been suggested by genetic interactions with the CIN8-encoded kinesin-like protein (40) Western blot analysis using affinity-purified anti-Spc110p antibodies was performed as described (26) . Strains Wx178-3A and Wx209-8A carrying the mutations mps2-1 or cdc31-2, respectively, were each grown at room temperature to mid-logarithmic phase (doubling times = 2.67 and 3 hours, respectively).
Each culture was then shifted to the restrictive temperature of 37 o C for 4.5 hours, after which total cell protein extracts were obtained from 1 ml aliquots by trichloroacetic acid precipitation as described (26) .
Separate cultures were treated with 6 µM α-factor at room temperature and total cell protein extracts were obtained from 1 ml aliquots after 1.5 doublings (>96% shmoo morphology). The cultures were then washed with pre-warmed YPD and released from the α-factor arrest in YPD at 37 were grown under different conditions. Galactose induction during the G1 arrest was performed as described previously (29) with the exception that cells were held at the arrest during the induction by the further addition of 10 µM α-factor after two hours. Lanes 1 and 2, asynchronous cultures. Lanes 3-6, cells arrested during the G1 stage of the cell cycle by the addition of 10 µM α-factor. Lanes 7-10, galactose induction during the G1 arrest. 120-(p120) and 112-kD (p112) Spc110p isoforms are indicated. The high-mobility signal present in lanes 9 and 10 results from the galactose-induced expression of GST-Mps1p and is visualized due to cross-reactivity between the affinity-purified antiSpc110p antibodies (raised against a GST fusion to the coiled-coil region of Spc110p (26)) and the GST-Mps1p fusion protein. The apparent molecular weight of GST-Mps1p in lanes 9 and 10 is 150 kDa, which is in agreement with previous findings (6,38) despite a predicted molecular weight of 112 kDa. Furthermore, the 150 kDa band in lanes 9 and 10 is the only protein reacting with anti-GST antibodies in a Western blot analysis (data not shown). , containing residues 265-755 within the central coiled-coil (26) , and myelin basic protein (MBP) were also used as substrates. Kinase assays were boiled for 4 minutes in SDS-PAGE buffer prior to separation on 12% SDS-polyacrylamide gels (42) . The dried gels were exposed to autoradiography film or a phosphorimager screen. Lane 1, 12xHIS-Spc110-201p (756∆) expressed from plasmid pDF47 with no GST-Mps1p added to the reaction. Lane 2, 12xHIS-Spc110-201p (756∆) expressed from plasmid pDF47 with GST-Mps1p added to the reaction. Lane 3, 12xHIS-Spc110p expressed from by guest on July 7, 2017 http://www.jbc.org/ Downloaded from plasmid pDF48 with GST-Mps1p added to the reaction. Lane 4, expression plasmid pQE32 containing no fusion protein with GST-Mps1p added to the reaction. Lanes 5 and 6, Western blot analysis using anti-MRGS antibodies (Qiagen, Valencia, CA) as described in (26) to determine the mobility of 12xHIS-Spc110-201p (756∆) expressed from plasmid pDF47 (lane 5) and 12xHIS-Spc110 expressed from plasmid pDF48 (lane 6). Lane 7, no substrates added to the reaction. GST-Spc110p containing alanine substitutions at the indicated residues were constructed and purified as described in Experimental Procedures. Approximately 0.2 µg were used as substrates for in vitro GST-Mps1p kinase assays as described in Experimental Procedures, after which reactions were boiled for 4 minutes in SDS-PAGE buffer prior to separation through a 10% SDS-polyacrylamide gel (42) . The gel was stained with Coomassie Brilliant Blue (A), dried, and exposed to a phosphorimager screen (B). Arrows indicate the mobility of full-length GST-Spc110p . Lane 1, wild-type GST-Spc110p (pDV29) without GST-Mps1p. Lanes 2-6: GST-Mps1p kinase assay using as substrate wild-type GST-Spc110p (pDV29, lane 2), GST-Spc110p containing the T64A mutation (pJK4, lane 3), the T68A mutation (pJK2, lane 4), the T64A, T68A double mutation (pJK7, lane 5), or the triple S60A, T64A, T68A mutation (pJK20, lane 6). Plasmids containing mutations in the phosphorylated residues of Spc110p were transformed into the indicated strains and plated on SD-uracil low adenine medium at 30 o C and 37 o C. The requirement for uracil maintains selection on the plasmids carrying alleles of SPC110 . If the mutant alleles are not functional, then these cells require the presence of plasmid pHS26 (expressing wild-type SPC110 ) and form solid red colonies. However, if these mutant alleles are functional, then the cells form red colonies with white sectors. S36D, S60D, T64D, T68D  S36A, S60A, T64A, T68A  S60A, T64A, T68A  T64A, T68A  S36A   1  2  3  4  5  6 Figure 7 
